3,288 Shares in Lam Research Co. (NASDAQ:LRCX) Acquired by Unigestion Holding SA

Share on StockTwits

Unigestion Holding SA bought a new stake in shares of Lam Research Co. (NASDAQ:LRCX) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,288 shares of the semiconductor company’s stock, valued at approximately $760,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. raised its position in shares of Lam Research by 2.2% in the second quarter. BlackRock Inc. now owns 11,392,897 shares of the semiconductor company’s stock valued at $2,140,039,000 after buying an additional 248,314 shares during the last quarter. Janus Henderson Group PLC raised its holdings in Lam Research by 2.1% in the second quarter. Janus Henderson Group PLC now owns 5,432,134 shares of the semiconductor company’s stock valued at $1,020,373,000 after acquiring an additional 112,508 shares in the last quarter. Nuveen Asset Management LLC raised its holdings in Lam Research by 655.7% in the second quarter. Nuveen Asset Management LLC now owns 2,502,249 shares of the semiconductor company’s stock valued at $470,022,000 after acquiring an additional 2,171,131 shares in the last quarter. Northern Trust Corp raised its holdings in Lam Research by 1.9% in the second quarter. Northern Trust Corp now owns 2,067,883 shares of the semiconductor company’s stock valued at $388,431,000 after acquiring an additional 38,448 shares in the last quarter. Finally, AQR Capital Management LLC raised its holdings in Lam Research by 20.5% in the second quarter. AQR Capital Management LLC now owns 1,571,906 shares of the semiconductor company’s stock valued at $295,267,000 after acquiring an additional 267,189 shares in the last quarter. 88.68% of the stock is owned by institutional investors.

Shares of Lam Research stock traded down $1.43 during trading on Friday, hitting $272.68. 1,373,000 shares of the stock were exchanged, compared to its average volume of 2,042,073. Lam Research Co. has a 12 month low of $122.64 and a 12 month high of $282.88. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.99 and a current ratio of 3.59. The stock’s fifty day moving average is $247.19 and its 200 day moving average is $210.36. The stock has a market cap of $40.32 billion, a PE ratio of 18.74, a P/E/G ratio of 1.36 and a beta of 1.67.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 23rd. The semiconductor company reported $3.18 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.01 by $0.17. Lam Research had a net margin of 22.38% and a return on equity of 43.11%. The company had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same quarter last year, the firm posted $3.36 EPS. The business’s revenue for the quarter was down 7.1% on a year-over-year basis. Sell-side analysts anticipate that Lam Research Co. will post 15.04 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 16th. Stockholders of record on Tuesday, October 1st were given a dividend of $1.15 per share. This is a positive change from Lam Research’s previous quarterly dividend of $1.10. The ex-dividend date was Monday, September 30th. This represents a $4.60 annualized dividend and a dividend yield of 1.69%. Lam Research’s dividend payout ratio (DPR) is 31.62%.

In other Lam Research news, SVP Vahid Vahedi sold 12,007 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $220.00, for a total transaction of $2,641,540.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Richard A. Gottscho sold 2,497 shares of the company’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $273.93, for a total transaction of $684,003.21. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 88,202 shares of company stock valued at $21,620,104. Insiders own 0.43% of the company’s stock.

Several analysts recently issued reports on the stock. Mizuho upped their price target on shares of Lam Research from $194.00 to $225.00 and gave the company a “neutral” rating in a report on Thursday, October 24th. They noted that the move was a valuation call. Cfra set a $210.00 price target on shares of Lam Research and gave the company a “hold” rating in a report on Saturday, August 31st. Nomura upped their price target on shares of Lam Research from $216.00 to $225.00 and gave the company a “neutral” rating in a report on Thursday, October 24th. Citigroup increased their target price on shares of Lam Research from $282.00 to $330.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, Royal Bank of Canada increased their target price on shares of Lam Research from $230.00 to $273.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Twelve equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $258.58.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition product for copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatment; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition (ALD) products; and VECTOR plasma-enhanced CVD ALD products.

See Also: What is a dividend reinvestment plan?

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.